Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Monitoring neuromyelitis optica activity.
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis.
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
Update on multiple sclerosis treatments.
A dorsiflexion assist orthosis reduces the physiological cost and mitigates deterioration in strength and balance associated with walking in people with Multiple Sclerosis.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research.
Anesthetic management of a patient with multiple sclerosis undergoing cesarean section with low dose epidural bupivacaine.
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
Neural stem cell diversity and proteomics.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Molecular pathogenesis of neuromyelitis optica.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Vitamin D: Health Panacea or false Prophet?
Treatment with interferon beta for multiple sclerosis.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
Frequency of reported European ancestry among multiple sclerosis patients from four cities in the southern and southeastern regions of Brazil.
Pages
« first
‹ previous
…
304
305
306
307
308
309
310
311
312
…
next ›
last »